|
US3189617A
(en)
|
1961-02-03 |
1965-06-15 |
Sterling Drug Inc |
1-aryloxindoles and their preparation
|
|
DE1956237A1
(de)
|
1969-11-08 |
1971-05-13 |
Basf Ag |
Spiro-pyrrolizidon-oxindole
|
|
DE2113343A1
(de)
|
1971-03-19 |
1972-09-21 |
Thiemann Chem Pharm Fab |
Indolo[2,3-b] chinolone und Verfahren zu ihrer Herstellung
|
|
US3723459A
(en)
|
1971-04-23 |
1973-03-27 |
Mc Neil Labor Inc |
2-oxospiro (indoline -3,4{40 -thiochroman) derivatives
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
CH577461A5
(enExample)
|
1975-08-13 |
1976-07-15 |
Robins Co Inc A H |
|
|
US4670566A
(en)
|
1979-07-12 |
1987-06-02 |
A. H. Robins Company, Incorporated |
3-methyl-hio-4-(5-, 6-, or 7-)phenylindolindolin-2-ones
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US4440785A
(en)
|
1980-10-30 |
1984-04-03 |
A. H. Robins Company, Inc. |
Methods of using 2-aminobiphenylacetic acids, esters, and metal salts thereof to treat inflammation
|
|
US4438130A
(en)
|
1981-11-12 |
1984-03-20 |
The Upjohn Company |
Analgesic 1-oxa-, aza- and thia-spirocyclic compounds
|
|
JPS60142984A
(ja)
|
1983-12-28 |
1985-07-29 |
Kyorin Pharmaceut Co Ltd |
新規なスピロピロリジン−２，５−ジオン誘導体およびその製造法
|
|
US4569942A
(en)
|
1984-05-04 |
1986-02-11 |
Pfizer Inc. |
N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
|
|
JPS6130554A
(ja)
|
1984-07-23 |
1986-02-12 |
Ono Pharmaceut Co Ltd |
プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
|
|
US4690943A
(en)
|
1984-09-19 |
1987-09-01 |
Pfizer Inc. |
Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
|
|
US4721721A
(en)
|
1984-12-18 |
1988-01-26 |
Rorer Pharmaceutical Corporation |
6-(4-thiazole) compounds, cardiotonic compositions including the same, and their uses
|
|
DE3608088C2
(de)
|
1986-03-07 |
1995-11-16 |
Schering Ag |
Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten
|
|
WO1993012786A1
(en)
|
1986-07-10 |
1993-07-08 |
Howard Harry R Jr |
Indolinone derivatives
|
|
JP2716986B2
(ja)
|
1987-07-17 |
1998-02-18 |
シエーリング アクチエンゲゼルシヤフト |
９‐ハロゲン‐（ｚ）‐プロスタグランジン誘導体、その製法及び薬剤としてのその使用
|
|
US5182289A
(en)
|
1988-06-14 |
1993-01-26 |
Schering Corporation |
Heterobicyclic compounds having antiinflammatory activity
|
|
ES2110965T3
(es)
|
1989-07-25 |
1998-03-01 |
Taiho Pharmaceutical Co Ltd |
Derivado de oxoindol.
|
|
DE3932953A1
(de)
|
1989-10-03 |
1991-04-11 |
Boehringer Mannheim Gmbh |
Neue 2-bicyclo-benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
DE3935514A1
(de)
|
1989-10-25 |
1991-05-02 |
Boehringer Mannheim Gmbh |
Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
|
|
US5304121A
(en)
|
1990-12-28 |
1994-04-19 |
Boston Scientific Corporation |
Drug delivery system making use of a hydrogel polymer coating
|
|
US5023265A
(en)
|
1990-06-01 |
1991-06-11 |
Schering Corporation |
Substituted 1-H-pyrrolopyridine-3-carboxamides
|
|
US5484778C1
(en)
|
1990-07-17 |
2001-05-08 |
Univ Cleveland Hospitals |
Phthalocynine photosensitizers for photodynamic therapy and methods for their use
|
|
WO1992009577A1
(en)
|
1990-11-22 |
1992-06-11 |
Janssen Pharmaceutica N.V. |
Isonicotinic acid derivatives and related spiro compounds with herbicidal action
|
|
US5116854A
(en)
|
1991-06-28 |
1992-05-26 |
Pfizer Inc. |
Anti-inflammatory 1-heteroaryl-3-acyl-2-oxindoles
|
|
FR2708605A1
(fr)
|
1993-07-30 |
1995-02-10 |
Sanofi Sa |
Dérivés du N-sulfonylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
|
|
US5686624A
(en)
|
1992-01-30 |
1997-11-11 |
Sanofi |
1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
|
|
US5849780A
(en)
|
1992-01-30 |
1998-12-15 |
Sanofi |
1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
|
|
FR2686878B1
(fr)
|
1992-01-30 |
1995-06-30 |
Sanofi Elf |
Derives du n-sulfonyl oxo-2 indole, leur preparation, les compositions pharmaceutiques en contenant.
|
|
US5663431A
(en)
|
1992-01-30 |
1997-09-02 |
Sanofi |
1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present
|
|
SK283413B6
(sk)
|
1992-08-06 |
2003-07-01 |
Warner-Lambert Company |
2-Tioindoly, 2-indolíntióny a polysulfidy, ich selénové analógy a farmaceutické prostriedky na ich báze
|
|
US5278162A
(en)
|
1992-09-18 |
1994-01-11 |
The Du Pont Merck Pharmaceutical Company |
3,3'-disubstituted-1,3-dihydro-2H-pyrrolo[2,3-b]heterocyclic-2-one useful in the treatment of cognitive disorders of man
|
|
US5296478A
(en)
|
1992-10-07 |
1994-03-22 |
The Dupont Merck Pharmaceutical Co. |
1-substituted oxindoles as cognition enhancers
|
|
US5776936A
(en)
|
1992-11-13 |
1998-07-07 |
Pharmacia & Upjohn Company |
Marcfortine/paraherquamide derivatives useful as antiparasitic agents
|
|
DE4242451A1
(de)
|
1992-12-16 |
1994-06-23 |
Basf Ag |
Verfahren zur Herstellung von 5-Ringheterocyclen
|
|
US5298522A
(en)
|
1993-01-22 |
1994-03-29 |
Pfizer Inc. |
6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
|
|
US5886026A
(en)
|
1993-07-19 |
1999-03-23 |
Angiotech Pharmaceuticals Inc. |
Anti-angiogenic compositions and methods of use
|
|
FR2708606B1
(fr)
|
1993-07-30 |
1995-10-27 |
Sanofi Sa |
Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
|
|
US5502072A
(en)
|
1993-11-26 |
1996-03-26 |
Pfizer Inc. |
Substituted oxindoles
|
|
AT400950B
(de)
|
1994-02-04 |
1996-04-25 |
Immodal Pharmaka Gmbh |
Verfahren zur technischen herstellung definierter isomerengemische aus verbindungen mit spirozyklischen - aminocarboxyl- und/oder spirozyklischen - aminocarbonyl-systemen
|
|
AU2310895A
(en)
|
1994-04-07 |
1995-10-30 |
Cemaf |
Novel spiro{indole-pyrrolidine} derivatives as melatoninergic agonists, method for preparing same and use thereofas a drug
|
|
FR2722195B1
(fr)
|
1994-07-07 |
1996-08-23 |
Adir |
Nouveaux derives de 1,3-dihydro-2h-pyrrolo(2,3-b) pyridin-2-ones et oxazolo(4,5-b) pyridin-2(3h)-ones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
US5618819A
(en)
|
1994-07-07 |
1997-04-08 |
Adir Et Compagnie |
1,3-dihydro-2H-pyrrolo[2,3-b]pyridin-2-one and oxazolo[4,5-b]pyridin-2-(3H)-one compounds
|
|
US6099562A
(en)
|
1996-06-13 |
2000-08-08 |
Schneider (Usa) Inc. |
Drug coating with topcoat
|
|
FR2740136B1
(fr)
|
1995-10-24 |
1998-01-09 |
Sanofi Sa |
Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
|
|
CA2235686C
(en)
|
1995-10-24 |
2007-06-26 |
Sanofi |
Indolin-2-one derivatives, process for their production and the pharmaceutical compositions containing them
|
|
HUP9600855A3
(en)
|
1996-04-03 |
1998-04-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for producing tenidap
|
|
JPH1095766A
(ja)
|
1996-09-19 |
1998-04-14 |
Sanwa Kagaku Kenkyusho Co Ltd |
アセトアミド誘導体、及びその用途
|
|
FR2757157B1
(fr)
|
1996-12-13 |
1999-12-31 |
Sanofi Sa |
Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
|
|
EP0989856B1
(de)
|
1997-01-20 |
2010-05-12 |
IMMODAL PHARMAKA GESELLSCHAFT m.b.H. |
Verfahren und stoffe zur freisetzung eines wachstumsfaktors aus endothelzellen, und nach dem verfahren freigesetzter wachstumsfaktor sowie seine verwendung
|
|
NO317155B1
(no)
|
1997-02-04 |
2004-08-30 |
Ono Pharmaceutical Co |
<omega>-cykloalkyl-prostagladin-E<N>2</N>-derivater
|
|
KR20000070903A
(ko)
|
1997-02-10 |
2000-11-25 |
오노 야꾸힝 고교 가부시키가이샤 |
11,15-ｏ-디알킬프로스타글란딘 ｅ 유도체, 이것의 제조 방법 및 이것을 유효 성분으로 함유하는 약제
|
|
US6416780B1
(en)
|
1997-05-07 |
2002-07-09 |
Galen (Chemicals) Limited |
Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
|
|
WO1999033794A1
(en)
|
1997-12-25 |
1999-07-08 |
Ono Pharmaceutical Co., Ltd. |
φ-CYCLOALKYL-PROSTAGLANDIN E2 DERIVATIVES
|
|
JP4087938B2
(ja)
|
1998-02-04 |
2008-05-21 |
高砂香料工業株式会社 |
ヒノキチオ−ル類の分岐サイクロデキストリン包接化合物からなる抗菌剤およびそれを含有する組成物
|
|
SK285908B6
(sk)
|
1998-04-01 |
2007-10-04 |
Nortran Pharmaceuticals Inc. |
Aminocyklohexyléterová zlúčenina, kompozícia obsahujúca túto zlúčeninu, použitie tejto zlúčeniny pri výrobe liečiva a pri liečbe
|
|
US20040038970A1
(en)
|
1998-06-12 |
2004-02-26 |
Societe De Conseils De Recherches Etd' Application Scientifiques, S.A.S. A Paris, France Corp. |
Beta-carboline compounds
|
|
US6235780B1
(en)
|
1998-07-21 |
2001-05-22 |
Ono Pharmaceutical Co., Ltd. |
ω-cycloalkyl-prostaglandin E1 derivatives
|
|
WO2000006556A1
(en)
|
1998-07-27 |
2000-02-10 |
Abbott Laboratories |
Substituted oxazolines as antiproliferative agents
|
|
US6407101B1
(en)
|
1999-05-04 |
2002-06-18 |
American Home Products Corporation |
Cyanopyrroles
|
|
US6355648B1
(en)
|
1999-05-04 |
2002-03-12 |
American Home Products Corporation |
Thio-oxindole derivatives
|
|
ES2258459T3
(es)
|
1999-05-21 |
2006-09-01 |
Bristol-Myers Squibb Company |
Pirrolotriazinas inhibidoras de quinasas.
|
|
WO2001006984A2
(en)
|
1999-07-21 |
2001-02-01 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Small molecules useful in the treatment of inflammatory disease
|
|
CZ2002203A3
(cs)
|
1999-07-21 |
2002-08-14 |
Astrazeneca Ab |
Spirooxindolové deriváty
|
|
US6566372B1
(en)
|
1999-08-27 |
2003-05-20 |
Ligand Pharmaceuticals Incorporated |
Bicyclic androgen and progesterone receptor modulator compounds and methods
|
|
CA2394229C
(en)
|
1999-11-26 |
2010-04-13 |
Mcgill University |
Loci for idiopathic generalized epilepsy, mutations thereof and method using same to assess, diagnose, prognose or treat epilepsy
|
|
FR2807038B1
(fr)
|
2000-04-03 |
2002-08-16 |
Sanofi Synthelabo |
Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
|
|
US20020045566A1
(en)
|
2000-10-13 |
2002-04-18 |
Gribkoff Valentin K. |
Selective maxi-K potassium channel openers functional under conditions of high intracellular calcium concentration, methods and uses thereof
|
|
IL154928A0
(en)
|
2000-11-10 |
2003-10-31 |
Lilly Co Eli |
3-substituted oxindole beta 3 agonists
|
|
US6670357B2
(en)
|
2000-11-17 |
2003-12-30 |
Bristol-Myers Squibb Company |
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
|
|
US20030078278A1
(en)
|
2001-06-26 |
2003-04-24 |
Pfizer Inc. |
Spiropiperidine compounds as ligands for ORL-1 receptor
|
|
EP1444224B1
(en)
|
2001-08-14 |
2006-05-03 |
Eli Lilly And Company |
3-substituted oxindole beta-3 agonists
|
|
WO2003037890A2
(en)
|
2001-11-01 |
2003-05-08 |
Icagen, Inc. |
Piperidines
|
|
DE60235114D1
(de)
|
2001-11-01 |
2010-03-04 |
Icagen Inc |
Pyrazolamide zur anwendung in der behandlung von schmerz
|
|
ATE297925T1
(de)
|
2001-11-20 |
2005-07-15 |
Lilly Co Eli |
3-substituierte oxindol beta 3 agonisten
|
|
SE0104341D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New use
|
|
JP2005519921A
(ja)
|
2002-01-28 |
2005-07-07 |
ファイザー株式会社 |
Ｏｒｌ−１受容体リガンドとしてのｎ置換スピロピペリジン化合物
|
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
WO2003078394A1
(en)
|
2002-03-15 |
2003-09-25 |
Eli Lilly And Company |
Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
|
|
GB0213715D0
(en)
|
2002-06-14 |
2002-07-24 |
Syngenta Ltd |
Chemical compounds
|
|
BR0312092A
(pt)
|
2002-06-25 |
2005-03-22 |
Wyeth Corp |
Uso de derivados de tio-oxindol no tratamento de distúrbios da pele
|
|
IL165395A0
(en)
|
2002-06-25 |
2006-01-15 |
Wyeth Corp |
Use of thio-oxubdile derivatives in treatment of hormone-related conditions
|
|
US7256218B2
(en)
|
2002-11-22 |
2007-08-14 |
Jacobus Pharmaceutical Company, Inc. |
Biguanide and dihydrotriazine derivatives
|
|
JP2007502856A
(ja)
|
2003-05-16 |
2007-02-15 |
ファイザー・プロダクツ・インク |
精神病性障害および抑うつ性障害の治療
|
|
BRPI0410419A
(pt)
|
2003-05-16 |
2006-05-30 |
Pfizer Prod Inc |
tratamento para a ansiedade com ziprasidona
|
|
CN1780626A
(zh)
|
2003-05-16 |
2006-05-31 |
辉瑞产品公司 |
双相性精神障碍和相关症状的治疗
|
|
EP1626722A1
(en)
|
2003-05-16 |
2006-02-22 |
Pfizer Products Inc. |
Method for enhancing cognition using ziprasidone
|
|
KR20060037409A
(ko)
|
2003-07-30 |
2006-05-03 |
제논 파마슈티칼스 인크. |
피페라진 유도체 및 그의 치료제로서의 용도
|
|
DE10337184A1
(de)
|
2003-08-13 |
2005-03-10 |
Gruenenthal Gmbh |
Substituierte 3-Pyrrolidin-Indol-Derivate
|
|
WO2005016913A1
(en)
|
2003-08-19 |
2005-02-24 |
Pfizer Japan, Inc. |
Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders
|
|
WO2005035498A1
(ja)
*
|
2003-10-08 |
2005-04-21 |
Dainippon Sumitomo Pharma Co., Ltd. |
含窒素二環性化合物の摂食調節剤としての用途
|
|
EP1557166A1
(en)
|
2004-01-21 |
2005-07-27 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
|
|
GB0406867D0
(en)
|
2004-03-26 |
2004-04-28 |
F2G Ltd |
Antifungal agents
|
|
WO2005092858A2
(en)
|
2004-03-29 |
2005-10-06 |
Pfizer Japan Inc. |
Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonist
|
|
WO2005099689A1
(en)
|
2004-04-01 |
2005-10-27 |
Case Western Reserve University |
Topical delivery of phthalocyanines
|
|
GT200500063A
(es)
|
2004-04-01 |
2005-10-14 |
|
Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
|
|
CA2562399A1
(en)
|
2004-04-08 |
2005-10-20 |
Topotarget A/S |
Diphenyl - indol-2-on compounds and their use in the treatment of cancer
|
|
WO2005104711A2
(en)
|
2004-04-27 |
2005-11-10 |
Wyeth |
Purification of progesterone receptor modulators
|
|
MXPA06012660A
(es)
|
2004-05-05 |
2007-03-23 |
Unibioscreen Sa |
Derivados de naftalimida para el tratamiento de cancer.
|
|
TWI350168B
(en)
|
2004-05-07 |
2011-10-11 |
Incyte Corp |
Amido compounds and their use as pharmaceuticals
|
|
WO2005111024A1
(en)
|
2004-05-14 |
2005-11-24 |
Pfizer Products Inc. |
Pyrimidine derivatives for the treatment of abnormal cell growth
|
|
EP1758882A4
(en)
|
2004-06-24 |
2008-01-23 |
Incyte Corp |
AMID COMPOUNDS AND THEIR USE AS MEDICAMENTS
|
|
GT200500186A
(es)
|
2004-07-07 |
2006-03-02 |
|
Regimenes anticonceptivos con antagonistas del receptor de progesterona y kits
|
|
GT200500183A
(es)
|
2004-08-09 |
2006-04-10 |
|
Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
|
|
GT200500185A
(es)
|
2004-08-09 |
2006-04-10 |
|
Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos
|
|
JP4677323B2
(ja)
|
2004-11-01 |
2011-04-27 |
キヤノン株式会社 |
画像処理装置及び画像処理方法
|
|
BRPI0518281A2
(pt)
|
2004-11-18 |
2008-11-18 |
Incyte Corp |
inibidores de 11-beta hidroxilesteràide desidrogenase do tipo i e mÉtodos uso dos mesmos
|
|
DE102005007694A1
(de)
|
2005-02-18 |
2006-09-21 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
EA019566B1
(ru)
|
2005-02-22 |
2014-04-30 |
Дзе Риджентс Оф Дзе Юниверсити Оф Мичиган |
Низкомолекулярные ингибиторы mdm2
|
|
AR056968A1
(es)
*
|
2005-04-11 |
2007-11-07 |
Xenon Pharmaceuticals Inc |
Compuestos espiro-oxindol y composiciones farmacéuticas
|
|
MY145694A
(en)
|
2005-04-11 |
2012-03-30 |
Xenon Pharmaceuticals Inc |
Spiroheterocyclic compounds and their uses as therapeutic agents
|
|
AR056317A1
(es)
|
2005-04-20 |
2007-10-03 |
Xenon Pharmaceuticals Inc |
Compuestos de oxindol y composicion farmaceutica
|
|
AR053713A1
(es)
|
2005-04-20 |
2007-05-16 |
Xenon Pharmaceuticals Inc |
Compuestos heterociclicos y sus usos como agentes terapeuticos
|
|
AU2006242542A1
(en)
|
2005-04-29 |
2006-11-09 |
Wyeth |
Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles
|
|
AR057023A1
(es)
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
|
|
CA2620034C
(en)
|
2005-09-01 |
2013-10-01 |
F. Hoffmann-La Roche Ag |
Diaminopyrimidines as p2x3 and p2x2/3 modulators
|
|
JP2010522690A
(ja)
|
2006-10-12 |
2010-07-08 |
ゼノン・ファーマシューティカルズ・インコーポレイテッド |
三環式スピロオキシインドール誘導体および治療薬としてのその使用
|
|
WO2008046084A2
(en)
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Spiroheterocyclic compounds and their uses as therapeutic agents
|
|
RU2009117605A
(ru)
|
2006-10-12 |
2010-11-20 |
Ксенон Фармасьютикалз Инк. (Ca) |
ПРОИЗВОДНЫЕ СПИРО-(ФУРО[3,2-c]ПИРИДИН-3-3'-ИНДОЛ)-2'(1'H)-ОНА И РОДСТВЕННЫЕ ИМ СОЕДИНЕНИЯ ДЛЯ ЛЕЧЕНИЯ ОПОСРЕДОВАННЫХ НАТРИЕВЫМИ КАНАЛАМИ ЗАБОЛЕВАНИЙ, ТАКИХ КАК БОЛЬ
|
|
WO2008046082A2
(en)
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Use of heterocyclic compounds as therapeutic agents
|
|
WO2008046087A2
(en)
*
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Spiro compounds and their uses as therapeutic agents
|
|
WO2008046083A2
(en)
|
2006-10-12 |
2008-04-17 |
Xenon Pharmaceuticals Inc. |
Use of oxindole compounds as therapeutic agents
|
|
TW200833698A
(en)
|
2006-10-12 |
2008-08-16 |
Xenon Pharmaceuticals Inc |
Spiroheterocyclic compounds and their uses as therapeutic agents
|
|
WO2008060789A2
(en)
|
2006-10-12 |
2008-05-22 |
Xenon Pharmaceuticals Inc. |
Use of spiro-oxindole compounds as therapeutic agents
|
|
WO2008117050A1
(en)
|
2007-03-27 |
2008-10-02 |
Astrazeneca Ab |
Pyrazolyl-amino-substituted pyrazines and their use for the treatment of cancer
|
|
CA2741024A1
(en)
|
2008-10-17 |
2010-04-22 |
Xenon Pharmaceuticals Inc. |
Spiro-oxindole compounds and their use as therapeutic agents
|
|
WO2010045251A2
(en)
|
2008-10-17 |
2010-04-22 |
Xenon Pharmaceuticals, Inc. |
Spiro-oxindole compounds and their use as therapeutic agents
|
|
WO2010053998A1
(en)
|
2008-11-05 |
2010-05-14 |
Xenon Pharmaceuticals, Inc. |
Spiro-condensed indole derivatives as sodium channel inhibitors
|
|
WO2010078307A1
(en)
|
2008-12-29 |
2010-07-08 |
Xenon Pharmaceuticals Inc. |
Spiro-oxindole-derivatives as sodium channel blockers
|
|
WO2010132352A2
(en)
|
2009-05-11 |
2010-11-18 |
Xenon Pharmaceuticals Inc. |
Spiro compounds and their use as therapeutic agents
|
|
AR077252A1
(es)
|
2009-06-29 |
2011-08-10 |
Xenon Pharmaceuticals Inc |
Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos
|
|
US20110086899A1
(en)
|
2009-10-14 |
2011-04-14 |
Xenon Pharmaceuticals Inc. |
Pharmaceutical compositions for oral administration
|
|
AU2010306768B2
(en)
|
2009-10-14 |
2016-08-04 |
Xenon Pharmaceuticals Inc. |
Synthetic methods for spiro-oxindole compounds
|
|
MY165117A
(en)
|
2010-02-26 |
2018-02-28 |
Xenon Pharmaceuticals Inc |
Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents
|